Cite
HARVARD Citation
Gasbjerg, L. et al. (2021). Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3‐30)NH2 on GIP actions in humans. Diabetes, obesity & metabolism. 23 (1), pp. 68-74. [Online].